Cargando…

Associations between plasma tenofovir concentration and renal function markers in HIV-infected women

BACKGROUND: Tenofovir disoproxil fumarate (TDF) has been associated with kidney tubular dysfunction and reduced renal function. Limited studies were performed in Europe and Asia that related plasma tenofovir (TFV) concentration with renal function; no such studies to date have been performed on Afri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulubwa, Mwila, Rheeders, Malie, Fourie, Carla, Viljoen, Michelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AOSIS 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843126/ https://www.ncbi.nlm.nih.gov/pubmed/29568614 http://dx.doi.org/10.4102/sajhivmed.v17i1.458

Ejemplares similares

A retrospective descriptive investigation of adult patients receiving third-line antiretroviral therapy in the North West province, South Africa
por: Rudman, Christian, et al.
Publicado: (2020)

Parental reporting of adverse drug reactions in South Africa: An online survey
por: Pillay, Shavani, et al.
Publicado: (2021)

Standards of aminoglycoside therapeutic drug monitoring in a South African private hospital: perspectives and implications
por: du Toit, Mariette, et al.
Publicado: (2019)

Plasma tenofovir trough concentrations are associated with renal dysfunction in Japanese patients with HIV infection: a retrospective cohort study
por: Kunimoto, Yusuke, et al.
Publicado: (2016)

Tenofovir Alafenamide in Multimorbid HIV-Infected Patients With Prior Tenofovir-Associated Renal Toxicity
por: Walti, Laura N, et al.
Publicado: (2018)

The effect of tenofovir on renal function in HIV-positive pregnant women
por: Flanagan, Stuart, et al.
Publicado: (2014)

Tenofovir Concentration Is Not Enough in Intraocular Tissues of Patients With HIV infection
por: Qian, Yiwen, et al.
Publicado: (2023)

Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis
por: Mulubwa, Mwila, et al.
Publicado: (2019)

Tenofovir Alafenamide Plasma Concentrations Are Reduced in Pregnant Women Living With Human Immunodeficiency Virus (HIV): Data From the PANNA Network( )
por: Bukkems, Vera E, et al.
Publicado: (2021)

Proximal tubular renal dysfunction among HIV infected patients on Tenofovir versus Tenofovir sparing regimen in western Kenya
por: Karoney, Mercy Jelagat, et al.
Publicado: (2022)

Adherence Predictors in Pregnant Women Living with HIV on Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate
por: Eke, Ahizechukwu C
Publicado: (2022)

An overview of tenofovir and renal disease for the HIV-treating clinician
por: Venter, Willem D.F., et al.
Publicado: (2018)

Tenofovir-associated renal toxicity in a cohort of HIV infected patients in Ghana
por: Nartey, Edmund T., et al.
Publicado: (2019)

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity
por: Bonjoch, Anna, et al.
Publicado: (2016)

Tenofovir-Induced Renal Dysfunction Among HIV-Infected Patients: A Systematic Review
por: Shivakumar, Yogamba M, et al.
Publicado: (2023)

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate
por: Hermansson, Linn, et al.
Publicado: (2019)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
por: Lalley-Chareczko, Linden, et al.
Publicado: (2020)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

Pregnancy Outcomes in Pregnant Women with HIV on Tenofovir Disoproxil Fumarate (TDF) Compared to Tenofovir Alafenamide (TAF)
por: Thimm, Matthew A., et al.
Publicado: (2022)

Access to chronic medicines: patients’ preferences for a last kilometre medicine delivery service in Cape Town, South Africa
por: Adams, Siraaj, et al.
Publicado: (2021)

Population pharmacokinetics of tenofovir and tenofovir‐diphosphate in healthy women
por: Burns, Rebecca N., et al.
Publicado: (2015)

Renal function in HIV-infected children and adolescents treated with tenofovir disoproxil fumarate and protease inhibitors
por: Pontrelli, Giuseppe, et al.
Publicado: (2012)

Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV
por: McLaughlin, Milena M, et al.
Publicado: (2018)

Tenofovir-Diphosphate as a Marker of HIV Pre-exposure Prophylaxis Use Among East African Men and Women
por: Pyra, Maria, et al.
Publicado: (2019)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Factors Associated with Bone Mineral Density and Bone Resorption Markers in Postmenopausal HIV-Infected Women on Antiretroviral Therapy: A Prospective Cohort Study
por: Ellis, Christa, et al.
Publicado: (2021)

Equivalent Decline in Inflammation Markers with Tenofovir Disoproxil Fumarate vs. Tenofovir Alafenamide
por: Funderburg, Nicholas T., et al.
Publicado: (2016)

Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now
por: Mofenson, Lynne M.
Publicado: (2016)

Renal Dysfunction during Tenofovir Use in a Regional Cohort of HIV-Infected Individuals in the Asia-Pacific
por: Tanuma, Junko, et al.
Publicado: (2016)

Renal proximal tubulopathy in an HIV-infected patient treated with tenofovir alafenamide and gentamicin: a case report
por: Heron, Jack E., et al.
Publicado: (2020)

Vaginal microbiota and mucosal pharmacokinetics of tenofovir in healthy women using tenofovir and tenofovir/levonorgestrel vaginal rings
por: Thurman, Andrea Ries, et al.
Publicado: (2019)

1571 Risk factors for Tenofovir-associated Renal Dysfunction in HIV-positive Patients
por: Marcelin, Jasmine Riviere, et al.
Publicado: (2014)

Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir
por: Yilma, Daniel, et al.
Publicado: (2020)

Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients
por: Chen, Ruijun, et al.
Publicado: (2017)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

Proximal renal tubular function in HIV-infected children on tenofovir disoproxil fumarate for treatment of HIV infection at two tertiary hospitals in Harare, Zimbabwe
por: Mashingaidze-Mano, Runyararo, et al.
Publicado: (2020)

Prevalence of renal dysfunction among HIV infected patients receiving Tenofovir at Mulago: a cross-sectional study
por: Nyende, Louis, et al.
Publicado: (2020)

Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates
por: Mulubwa, Mwila, et al.
Publicado: (2020)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

Renal function change after switching tenofovir disoproxil fumarate for tenofovir alafenamide in the HIV-positive patients of a metropolitan sexual health service
por: Turner, Dane, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3ka4mmenr9i9fd41jgnidnk93v